BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10603899)

  • 21. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer (Br J Surg 2008; 95: 1029-1036).
    Corder AP; Iqbal M; Devaraj S
    Br J Surg; 2008 Nov; 95(11):1428-9; author reply 1429. PubMed ID: 18844282
    [No Abstract]   [Full Text] [Related]  

  • 22. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan.
    Saito H
    J Med Screen; 2006; 13 Suppl 1():S6-7. PubMed ID: 17227634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
    Malila N; Oivanen T; Hakama M
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer screening in the Czech Republic.
    Zavoral M
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S29-30. PubMed ID: 18368637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for rectal cancer: will it improve cure rates?
    Tweedle EM; Rooney PS; Watson AJ
    Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):639-48. PubMed ID: 17764916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epidemiology and screening of colorectal cancer].
    Faivre J
    Ann Pathol; 1997; 17 Suppl 5():17-9. PubMed ID: 9453716
    [No Abstract]   [Full Text] [Related]  

  • 27. Colonic screening and surveillance.
    Kronborg O
    Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):301-16. PubMed ID: 11355917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal cancer mortality in two areas of Tuscany with different screening exposures.
    Costantini AS; Martini A; Puliti D; Ciatto S; Castiglione G; Grazzini G; Zappa M
    J Natl Cancer Inst; 2008 Dec; 100(24):1818-21. PubMed ID: 19066268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of colorectal cancer.
    Winawer SJ
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Randomized controlled trial of sequence mass screening program for colorectal cancer].
    Liu X; Zheng S; Chen K; Ma X; Zhou L; Yu H; Yao K; Chen K; Cai S; Zhang S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):430-3. PubMed ID: 11860828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Screening for colorectal cancer: definitely implement].
    Jansen JB
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1776. PubMed ID: 18754309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal cancer screening: a guide to the guidelines.
    Deenadayalu VP; Rex DK
    Rev Gastroenterol Disord; 2007; 7(4):204-13. PubMed ID: 18192956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
    Malila N; Hakama M; Pukkala E
    Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal cancer. Which test is best?
    Cahill BA
    Adv Nurse Pract; 2005 Jan; 13(1):71-4. PubMed ID: 15679298
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening for colorectal cancer in average-risk populations.
    Lieberman D
    Am J Med; 2006 Sep; 119(9):728-35. PubMed ID: 16945604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updated colorectal cancer guidelines shift focus from intensive surveillance to screening.
    Levenson D
    Rep Med Guidel Outcomes Res; 2003 Feb; 14(4):7-9. PubMed ID: 12807131
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
    Loss J; Eichhorn C; Nagel E
    Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer.
    Van Gerpen R
    Ala Nurse; 2004 Dec-2005 Feb; 31(4):27-30; quiz 30-1. PubMed ID: 15662763
    [No Abstract]   [Full Text] [Related]  

  • 39. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective comparative evaluation of an office-based rapid immunological test with a Guaiac-based fecal occult blood test for colorectal cancer screening in general population with average-risk.
    Shastri YM; Loitsch S; Nowak R; Povse N; Stein J
    Clin Lab; 2008; 54(9-10):385-7. PubMed ID: 19097496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.